114 related articles for article (PubMed ID: 9529025)
1. Poorer survival of nulliparous women with endometrial carcinoma.
Salvesen HB; Akslen LA; Albrektsen G; Iversen OE
Cancer; 1998 Apr; 82(7):1328-33. PubMed ID: 9529025
[TBL] [Abstract][Full Text] [Related]
2. Parity and time interval since childbirth influence survival in endometrial cancer patients.
Albrektsen G; Heuch I; Wik E; Salvesen HB
Int J Gynecol Cancer; 2009 May; 19(4):665-9. PubMed ID: 19509568
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of angiogenesis and Ki-67, p53, and p21 expression: a population-based endometrial carcinoma study.
Salvesen HB; Iversen OE; Akslen LA
J Clin Oncol; 1999 May; 17(5):1382-90. PubMed ID: 10334522
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of parity in 493 uterine sarcoma patients.
Albrektsen G; Heuch I; Wik E; Salvesen HB
Int J Gynecol Cancer; 2009 Aug; 19(6):1062-7. PubMed ID: 19820369
[TBL] [Abstract][Full Text] [Related]
5. Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas.
Salvesen HB; Iversen OE; Akslen LA
Clin Cancer Res; 1998 Nov; 4(11):2779-85. PubMed ID: 9829742
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of inflammatory parameters and nutritional index in clinical stage IVB endometrial carcinomas.
Kiuchi K; Hasegawa K; Ochiai S; Motegi E; Kuno T; Kosaka N; Fukasawa I
J Obstet Gynaecol; 2019 Feb; 39(2):237-241. PubMed ID: 30370797
[TBL] [Abstract][Full Text] [Related]
7. Prospective multicenter validation confirms the prognostic superiority of the endometrial carcinoma prognostic index in international Federation of gynecology and obstetrics stage 1 and 2 endometrial carcinoma.
Baak JP; Snijders W; van Diermen B; van Diest PJ; Diepenhorst FW; Benraadt J
J Clin Oncol; 2003 Nov; 21(22):4214-21. PubMed ID: 14615450
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological characteristics, treatment and outcomes in uterine carcinosarcoma and grade 3 endometrial cancer patients: a comparative study.
Zhu J; Wen H; Bi R; Wu X
J Gynecol Oncol; 2016 Mar; 27(2):e18. PubMed ID: 26463439
[TBL] [Abstract][Full Text] [Related]
9. Reproductive history and prognosis in patients with operable breast cancer.
Korzeniowski S; Dyba T
Cancer; 1994 Sep; 74(5):1591-4. PubMed ID: 8062190
[TBL] [Abstract][Full Text] [Related]
10. Analysis of survival after laparoscopy in women with endometrial carcinoma.
Eltabbakh GH
Cancer; 2002 Nov; 95(9):1894-901. PubMed ID: 12404283
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
[TBL] [Abstract][Full Text] [Related]
12. Association of time since last birth, age at first birth and parity with breast cancer survival among parous women: a register-based study from Norway.
Alsaker MD; Opdahl S; Romundstad PR; Vatten LJ
Int J Cancer; 2013 Jan; 132(1):174-81. PubMed ID: 22511284
[TBL] [Abstract][Full Text] [Related]
13. Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients.
Binder PS; Peipert JF; Kallogjeri D; Brooks RA; Massad LS; Mutch DG; Powell MA; Thaker PH; McCourt CK
Am J Obstet Gynecol; 2016 Dec; 215(6):766.e1-766.e9. PubMed ID: 27457116
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of flow cytometric deoxyribonucleic acid index in endometrial carcinoma: comparison with other clinical-pathologic parameters.
Susini T; Rapi S; Savino L; Boddi V; Berti P; Massi G
Am J Obstet Gynecol; 1994 Feb; 170(2):527-34. PubMed ID: 8116708
[TBL] [Abstract][Full Text] [Related]
15. An aggregated analysis of hormonal factors and endometrial cancer risk by parity.
Schonfeld SJ; Hartge P; Pfeiffer RM; Freedman DM; Greenlee RT; Linet MS; Park Y; Schairer C; Visvanathan K; Lacey JV
Cancer; 2013 Apr; 119(7):1393-401. PubMed ID: 23280123
[TBL] [Abstract][Full Text] [Related]
16. L1 Cell Adhesion Molecule as a Predictor of Disease-Specific Survival and Patterns of Relapse in Endometrial Cancer.
Pasanen A; Tuomi T; Isola J; Staff S; Bützow R; Loukovaara M
Int J Gynecol Cancer; 2016 Oct; 26(8):1465-71. PubMed ID: 27648714
[TBL] [Abstract][Full Text] [Related]
17. Uterine carcinosarcoma and high-risk endometrial carcinomas: a clinicopathological comparison.
Zhang C; Hu W; Jia N; Li Q; Hua K; Tao X; Wang L; Feng W
Int J Gynecol Cancer; 2015 May; 25(4):629-36. PubMed ID: 25633654
[TBL] [Abstract][Full Text] [Related]
18. Tumor size: a better independent predictor of distant failure and death than depth of myometrial invasion in International Federation of Gynecology and Obstetrics stage I endometrioid endometrial cancer.
Chattopadhyay S; Cross P; Nayar A; Galaal K; Naik R
Int J Gynecol Cancer; 2013 May; 23(4):690-7. PubMed ID: 23518862
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of morphometric nuclear grade of endometrial carcinoma.
Salvesen HB; Iversen OE; Akslen LA
Cancer; 1998 Sep; 83(5):956-64. PubMed ID: 9731900
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic Association and Prognostic Value of Microcystic, Elongated, and Fragmented (MELF) Pattern in Endometrial Endometrioid Carcinoma.
Kihara A; Yoshida H; Watanabe R; Takahashi K; Kato T; Ino Y; Kitagawa M; Hiraoka N
Am J Surg Pathol; 2017 Jul; 41(7):896-905. PubMed ID: 28418994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]